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ABSTRACT
Objectives: To study the rate of isolation of Acinetobacter species, its antibiogram and associated risk factors.
Methods: Retrospective time bound study for 6 months. The study included 191 consecutive clinical significant isolates of Acinetobacter species 
isolated from various specimens. The identification and antibiotic susceptibility testing by modified Kirby Bauer and Vitek Compact system 2.
Results: Maximum isolation of Acinetobacter species was from suction tip (31.94%), sputum (19.89%), urine (14.66%), blood (10.47%), and others. 
The species was most sensitive to colistin (97.87%) and polymyxin B (99.43%). The species was most resistant to imipenem (72.62%) and gentamicin 
(66.66%). The common risk factors were invasive procedure, duration of intensive care unit stay, and malignancies.
Conclusion: Acinetobacter has emerged as a major nosocomial pathogen. Antibiotic resistance is on rise. Proper antibiotic stewardship is required 
to curtail antibiotic resistance in this region.
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INTRODUCTION
Acinetobacter baumannii, non-fermenting Gram-negative baciili has 
become an emerging pathogen especially in the hospitals owing to its 
ability to survive in adverse environmental conditions [1]. Acinetobacter 
species is associated with health care associated infections especially in 
patients on respiratory therapy equipment and indwelling catheters. The 
infections caused by this pathogen include pneumonia, septicemia, wound 
sepsis, urinary tract infection, endocarditis, and meningitis. A. baumannii is 
the most common species [2].
Antibiotic resistance and the ability of the organism to survive in the 
moist environment have contributed to the survival and spread of this 
pathogen in hospital settings [3].
The risk factors associated with Acinetobacter infections include 
presence of prosthesis, endotracheal intubation, intravenous catheters 
and prior antibiotic therapy, length of intensive care unit (ICU) and 
hospital stay, recent surgery, and invasive procedures [4].
The rate of antimicrobial resistance in this organism is very high, and 
thus the infections are difficult to treat. With the increase in the use of 
carbapenems to treat the resistant strains, there is a surge in the rates 
of carbapenem resistance. Use of polymyxin, colistin, and tigecycline is 
considered to treat the carbapenem resistant strains [5].
The knowledge of the prevalence and pattern of antimicrobial 
susceptibility pattern of Acinetobacter spp. is important [5,6].
The study is undertaken to evaluate the risk factors and antimicrobial 
resistance in Acinetobacter spp.
Aim
Clinicomicrobiological study of infections caused by Acinetobacter 
species.
Objective
1. To study the rate of isolation of Acinetobacter species
2. To study the antibiotic susceptibility pattern of Acinetobacter spp. 
by Vitek 2 and Kirby Bauer method
3. To study the risk factors associated with Acinetobacter spp. infections.
METHODS
A retrospective, hospital record-based study was undertaken from 
November 2015 to April 2016 in the central laboratory at KMC Hospital, 
Ambedkar circle, Mangalore.
The isolates of Acinetobacter species obtained from various clinical 
specimen: Exudate, urine, and blood from the patients were included 
in the study.
Processing of samples
All the samples for bacteriological culture were cultured aerobically 
on blood agar, chocolate agar, and MacConkey agar. Blood specimens 
were collected and incubated aerobically using BacT/ALERT system 
(bioMerieux, USA). Positive samples were sub-cultured by standard 
methods into blood agar, chocolate agar, and MacConkey’s medium 
and aliquot was taken from positive bottles for Gram-stain. The 
identification and antimicrobial susceptibility testing of the isolates 
to antimicrobial agents was performed using the Vitek 2 system 
(bioMerieux, France) [4].
The study has been approved by the Institutional Ethics Committee.
RESULTS
During a period of 6-month, i.e., from November 2015 to April 2016, 
a total of 15611 clinical samples were received. Out of these samples, 
191 (1.23%) of Acinetobacter spp. were isolated. Out of 191 samples, 
111 samples (58.12%) were from inpatients, and 80 samples (41.88%) 
were from outpatients.
Maximum isolation of Acinetobacter species was from suction tip 
(31.94%), sputum (19.89%), urine (14.66%), blood (10.47%), and others.
Out of 191 isolates, 178 (93.2%) A. baumannii were isolated, 5 (2.6%) 
were Acinetobacter junii, and 8 (4.2%) were Acinetobacter lwoffii. The 
© 2017 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2017.v10i4.16596
Research Article
224
Asian J Pharm Clin Res, Vol 10, Issue 4, 2017, 223-224
 Shridhar and Bhat 
rate of isolation of Acinetobacter spp. was significant in inpatients and 
in the age group above ≥50 years, associated with comorbidities, and 
long hospital stay. Acinetobacter infection was seen more in males 
116 (60.73%) compared to females 75 (39.27%). The rate of isolation and 
Antibiogram of Acinetobacter spp. is  shown in Tables 1 and 2 respectively.
DISCUSSION
Acinetobacter spp. is the second most common non-fermenting bacteria 
isolated from clinical specimen especially in hospital settings [8]. The 
recent years have seen the emergence of this pathogen in ICUs [7].
In our study, the rate of isolation of Acinetobacter spp. from different 
clinical specimens is 1.23%. This statistics is similar to the findings 
of the study by Dash et al. in Odisha (3%), Tripathi et al. in Madhya 
Pradesh (1.02%), and Vaja et al. in Gujarat (4.8%) [9,10,11]. The 
prevalence rate of this study is less compared to 14% and 9.6% rates 
among the hospital isolates reported by Mostofi et al. in Tehran, Iran, 
and Joshi et al. in Pune, India, respectively [12,13].
In this study, Acinetobacter spp. was isolated from various clinical 
specimens such as blood, urine, suction tip, sputum, among which 
suction tip (31.9%) was the most common. The results are different 
from study by Dash et al. in Odisha and Vaja et al. in Gujarat. They 
have reported maximum isolation from pus/swab (56%) and blood 
(50%) [9,11].
The major risk factors for Acinetobacter spp. infections were 
age ≥50 years, length of stay in hospital, invasive procedures like 
catheterization, intubation, and mechanical ventilation with underlying 
comorbid conditions such as diabetes mellitus, similar to the findings of 
the studies published earlier [9,14,15].
In this study, 59.16% of the Acinetobacter isolates found to be multi-
drug-resistant (MDR) which is similar 54.7% in study by Dash et al. 
in Odisha [9]. In other studies, the rates of MDR isolates were 29% 
and 54% in Bhattacharyya et al. in West Bengal and Mostofi et al. in 
Tehran [12,16].
In our study, we found that the Acinetobacter spp. isolates were most 
sensitive to colistin, polymyxin B, and tigecycline, a similar observation 
was done in Dash et al., Odisha [9].
CONCLUSION
Acinetobacter spp. has emerged as a major nosocomial pathogen. 
Antibiotic resistance is on rise. Proper antibiotic stewardship is 
required. This study will help in formulating better infection control 
strategies to combat antibiotic resistance in this region.
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Table 1: Rate of isolation of Acinetobacter spp. isolated from 
different clinical specimen
Specimen Number of isolates (%)
Sputum 38 (19.89)
Wound swab 19 (9.95)




Table 2: Antibiotic resistance pattern of Acinetobacter spp.











Polymyxin B 0 (0)
Tigecycline 13 (8.72)
